Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q2 2019 · 10-Q
Revenue$8.13M$8.13M+24.6% vs Q2 2018 Net Income$53.67K$53.67K−90.1% vs Q2 2018 EPS Diluted$0.01$0.01−85.7% vs Q2 2018 Operating Income$496,564−56.8% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$167,895+424.1% Margins · derivedOperating margin6.1%−11.5 pt vs Q2 2018
Net margin0.7%−7.6 pt vs Q2 2018
ended May 31, 2019 · filed Jul 15, 2019 · 45 d after period end